Orix IX
NYSE IX
$39.30 -0.96 (-2.38%)
At close: Sep 18, 2026 · 4:00 PM EDT

Orix (IX) EBIT Margin Growth (3y) (2012 - 2026)

Analysis

Orix (IX) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Orix 44.18 Bn 44.51 Bn 4.68 Bn 301.00
2 Royalty Pharma 33.59 Bn 35.70 Bn - -2,649.00
3 Royal Gold 21.14 Bn 21.00 Bn 390.45 Mn 1,222.00
4 OR Royalties 6.88 Bn 6.81 Bn 82.22 Mn 3,065.00
5 Encore Capital 2.11 Bn 1.93 Bn 455.04 Mn 1,073.00
6 Atlanticus Holdings 1.41 Bn 851.50 Mn 686.46 Mn -134.00
7 Jefferson Capital 1.18 Bn 1.16 Bn - -
8 Lufax Holding 1.04 Bn -1.23 Bn - -2,004.00
9 Upbound 998.67 Mn 893.37 Mn 594.84 Mn -392.00
10 Metalla Royalty & Streaming 942.93 Mn 931.86 Mn 4.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 301.00
Mar 31, 2026 -3,834.00
Dec 31, 2025 50.00
Sep 30, 2025 555.00
Jun 30, 2025 331.00
Mar 31, 2025 402.00
Dec 31, 2024 1,731.00
Sep 30, 2024 -1,300.00
Jun 30, 2024 -457.00
Mar 31, 2024 5,016.00
Dec 31, 2023 147.00
Sep 30, 2023 -175.00
Jun 30, 2023 380.00
Mar 31, 2023 4,224.00
Dec 31, 2022 124.00
Sep 30, 2022 -517.00
Jun 30, 2022 -105.00
Mar 31, 2022 -947.00
Dec 31, 2021 -13.00
Sep 30, 2021 124.00